Benilton Carvalho,
UNICAMP, Campinas

BIPMed is an initiative of five Research Innovation and Dissemination Centers (RIDCs) supported by FAPESP: The Brazilian Research Institute for Neuroscience and Neurotechnology (BRAINN), coordinated by Dr. Fernando Cendes; the Center for Computational Science and Engineering (CCES), coordinated by Dr. Munir Skaf; the Center for Research in Cell Therapy (CTC), coordinated by Dr. Marco Antonio Zago; Obesity and Comorbidities Research Center (OCRC), coordinated by Dr. Licio Augusto Velloso and the Center for Research on Inflammatory Diseases (CRID), coordinated by Dr. Fernando Queiroz Cunha.

Precision Medicine has emerged recently as a concept in which scientific knowledge and technology come together to provide the foundation for the 21^st century medicine. It embraces translational research, genomic medicine and personalized medicine and proposes a new level of integration of data in order to improve health care.

BIPMed is currently based on a recently launched software platform, built following the guidelines and principles prosed by of the Global Alliance for Genomics and Health (http://www.genomicsandhealth.org ), and observing the responsible and ethical sharing of genomic and clinical data. This platform is the first of its kind in Latin America and aims to offer public access to genomic and phenotypic data. It is intended to be used by clinicians and scientists all over the world, to share and obtain information about various aspects of genomic medicine and human health, as well as to support dissemination and training in the areas of human molecular genetics, computational biology and others. Thus, BIPMed is already playing an essential role in the development of precision medicine, allowing for significant advances in health care and research.